These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8610522)

  • 1. Neural tolerability of iodixanol in mice and dogs after single and repeated intracisternal administration.
    Larsen LE; Heglund IF; Fabian R; Walday P; Blazak WF
    Acta Radiol Suppl; 1995; 399():238-43. PubMed ID: 8610522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS-effects from subarachnoid injections of iohexol and the non-ionic dimers iodixanol and iotrolan in the rabbit.
    Sundgren P; Bååth L; Maly P
    Acta Radiol; 1995 May; 36(3):307-11. PubMed ID: 7742128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural tolerance of the non-ionic dimers iodixanol and iotrolan and the non-ionic monomer iopamidol during myelography in non-anaesthetised rabbits.
    Maly P; Sundgren P; Bååth L; Walday P
    Acta Radiol; 1995 Nov; 36(6):644-8. PubMed ID: 8519577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of iodixanol in experimental animals.
    Walday P; Heglund IF; Golman K; Cornacoff J; Holtz E
    Acta Radiol Suppl; 1995; 399():204-12. PubMed ID: 8610517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats.
    Idée JM; Lancelot E; Berthommier C; Couturier-Goulas V; Vazin V; Corot C
    Fundam Clin Pharmacol; 2000; 14(1):11-8. PubMed ID: 10681069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to iotrolan after subarachnoid injection in animals.
    Press WR; Mützel W; Schöbel C
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():126-33. PubMed ID: 2568780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [General pharmacological study of iodixanol, a new non-ionic isotonic contrast medium].
    Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Makino M; Hagiwara T; Hirohashi M; Nomura M; Algate DR
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():133-51. PubMed ID: 7490785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ; Scholz P; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
    Morris TW; Dukovic D; Pagani E
    Acad Radiol; 1995 Jan; 2(1):33-7. PubMed ID: 9419521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
    Wang YC; Tang A; Chang D; Zhang SJ; Ju S
    Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of coronary injections of iodixanol, iopamidol, and ioxaglate on contractility and electrophysiology.
    Morris TW; Dukovic D; Pagani E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S99-101. PubMed ID: 7928282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to rats by repeated intravenous administration for 4 weeks with a 4-week recovery period].
    Ohno H; Crome SJ; Furuhama K; Nomura M; Onodera T
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():67-85. PubMed ID: 7490790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacokinetics and general toxicology of iodixanol.
    Heglund IF; Michelet AA; Blazak WF; Furuhama K; Holtz E
    Acta Radiol Suppl; 1995; 399():69-82. PubMed ID: 8610532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast media-induced ventricular fibrillation: an experimental study of the effects of dimeric contrast media during wedged catheter injection in dogs.
    Pedersen HK; Jacobsen EA; Refsum H
    Acad Radiol; 1994 Oct; 1(2):136-44. PubMed ID: 9419477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
    Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium].
    Igarashi M; Nakayama S; Jones E; Shimada H
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():125-31. PubMed ID: 7490784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney.
    Deray G; Bagnis C; Jacquiaud C; Dubois M; Adabra Y; Jaudon C
    Invest Radiol; 1999 Jan; 34(1):1-4. PubMed ID: 9888047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs in vector-electrocardiography (VECG) predicting the fibrillatory propensity of iodixanol and mannitol solutions after injection into the left coronary artery of pigs.
    Chai CM; Almén T; Bååth L; Besjakov J; Towart R
    Acad Radiol; 2007 Feb; 14(2):162-77. PubMed ID: 17236989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
    Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
    Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.